Karuna Therapeutics, Inc.
KRTX · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $12 | $6 | $4 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $12 | $6 | $4 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -93.9% | -71.2% | – | – |
| Gross Profit | -$0 | $0 | $0 | -$0 |
| % Margin | -160.1% | 89.5% | 98.6% | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -75,393.9% | -2,440.8% | -387.3% | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -66,311.9% | -2,597.9% | -389% | – |
| EPS Diluted | -11.73 | -8.74 | -4.94 | -2.59 |
| % Growth | -34.2% | -76.9% | -90.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |